Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27780274 | 0.97 | ALDH1A1 (0.33) | ALDH1A1 | |
| Phosphoric Acid SCHEMBL27779615 | 0.87 | FDPS (0.40) | ALDH1A1 | |
| SCHEMBL17303184 | 0.84 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL8606468 | 0.82 | NFKB1 (0.33) | ALDH1A1 | |
| SCHEMBL10618555 | 0.80 | CA12 (0.36) | ALDH1A1 | |
| SCHEMBL627289 | 0.80 | — | — | |
| SCHEMBL627290 | 0.80 | — | — | |
| SCHEMBL361077 | 0.78 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL361436 | 0.78 | TSHR (0.30) | — | |
| SCHEMBL368093 | 0.77 | ALDH1A1 (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230405043-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2023-12-21 | — | — | US | claimed |
| US-20190134076-A1 | HCL-BINDING COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS | RENIBUS THERAPEUTICS, INC. | 2019-05-09 | — | — | US | claimed |
| WO-2017193024-A9 | HCL-BINDING COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | TRICIDA, INC. (US) | 2018-11-22 | — | — | WO | claimed |
| US-9993500-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2018-06-12 | — | — | US | claimed |
| US-20180021370-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2018-01-25 | — | — | US | claimed |
| WO-2017193024-A1 | HCL-BINDING COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | TRICIDA, INC. (US) | 2017-11-09 | — | — | WO | claimed |
| EP-3229816-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | Tricida Inc. (US) | 2017-10-18 | — | — | EP | claimed |
| WO-2016094685-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | TRICIDA, INC. (US) | 2016-06-16 | — | — | WO | claimed |
| US-9205107-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2015-12-08 | — | — | US | claimed |
| US-11992501-B2 | Compositions for and methods of treating acid-base disorders | RENOSIS, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-11986490-B2 | Compositions for and method of treating acid-base disorders | RENOSIS, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-20230405043-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2023-12-21 | — | — | US | disclosed |
| US-11738041-B2 | Proton-binding polymers for oral administration | RENOSIS, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| CN-109414453-B | Composition for treating acid-base imbalance | 特里赛达公司 | 2023-02-17 | — | — | CN | disclosed |
| WO-2000046274-A1 | PROCESS FOR THE MANUFACTURE OF FUNCTIONALIZED POLYPHENYLENE ETHERS | GENERAL ELECTRIC COMPANY (US) | 2000-08-10 | — | — | WO | disclosed |
| US-6096891-A | Process for the production of cyclic N,N'-dialkylureas | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2000-08-01 | — | — | US | disclosed |
| EP-0307775-B1 | Water dispersible, modified polyurethane thickener with improved high shear viscosity in aqueous systems | RHEOX INT (US) | 1993-11-03 | — | — | EP | disclosed |
| US-5023309-A | Polyetherurethane copolymer modified by a hydrophobic agent and a end group; resistant to microbiocides; good sag and leveling properties; paints; coatings | RHEOX, INC. (US) | 1991-06-11 | — | — | US | disclosed |
| WO-1989002451-A1 | WATER DISPERSIBLE, MODIFIED POLYURETHANE THICKENER WITH IMPROVED HIGH SHEAR VISCOSITY IN AQUEOUS SYSTEMS | NL CHEMICALS, INC. (US) | 1989-03-23 | — | — | WO | disclosed |
| EP-0307775-A2 | Water dispersible, modified polyurethane thickener with improved high shear viscosity in aqueous systems | RHEOX INTERNATIONAL, INC. (US) | 1989-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11992501-B2 | Compositions for and methods of treating acid-base disorders | SLC10A2, SLC10A1, SLC26A3 | ALDH1A1 1554/4885 |
| US-20190134076-A1 | HCL-BINDING COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS | SLC10A2, SLC10A1, SLC7A1 | ALDH1A1 1901/4885 |
| US-20180021370-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885 |
| US-11738041-B2 | Proton-binding polymers for oral administration | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885 |
| US-20230405043-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885 |
| US-11986490-B2 | Compositions for and method of treating acid-base disorders | SLC10A2, SLC10A1, GLS | ALDH1A1 773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.